Resurgence in HiSeq Sales Helps Drive Illumina Revenue Growth in Q1 2013 | GenomeWeb

Illumina's $331 million in revenue for the first quarter of 2013 was driven primarily by sales of its HiSeq instrument, consumables, and services business.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.